233 related articles for article (PubMed ID: 8252746)
1. Effects of different oral oestrogen formulations on insulin-like growth factor-I, growth hormone and growth hormone binding protein in post-menopausal women.
Kelly JJ; Rajkovic IA; O'Sullivan AJ; Sernia C; Ho KK
Clin Endocrinol (Oxf); 1993 Nov; 39(5):561-7. PubMed ID: 8252746
[TBL] [Abstract][Full Text] [Related]
2. Modulation by progestogens of the effects of oestrogen on hepatic endocrine function in postmenopausal women.
Nugent AG; Leung KC; Sullivan D; Reutens AT; Ho KK
Clin Endocrinol (Oxf); 2003 Dec; 59(6):690-8. PubMed ID: 14974909
[TBL] [Abstract][Full Text] [Related]
3. Sex steroid regulation of growth hormone secretion and action.
Ho KK; O'Sullivan AJ; Weissberger AJ; Kelly JJ
Horm Res; 1996; 45(1-2):67-73. PubMed ID: 8742122
[TBL] [Abstract][Full Text] [Related]
4. Effect of oestrogen status on serum levels of growth hormone-binding protein and insulin-like growth factor-I in non-pregnant and pregnant women.
Massa G; Igout A; Rombauts L; Frankenne F; Vanderschueren-Lodeweyckx M
Clin Endocrinol (Oxf); 1993 Nov; 39(5):569-75. PubMed ID: 8252747
[TBL] [Abstract][Full Text] [Related]
5. Metabolic effects of oestrogens: impact of the route of administration.
Ho KK; O'Sullivan AJ; Wolthers T; Leung KC
Ann Endocrinol (Paris); 2003 Apr; 64(2):170-7. PubMed ID: 12773957
[TBL] [Abstract][Full Text] [Related]
6. Contrasting effects of oral and transdermal routes of estrogen replacement therapy on 24-hour growth hormone (GH) secretion, insulin-like growth factor I, and GH-binding protein in postmenopausal women.
Weissberger AJ; Ho KK; Lazarus L
J Clin Endocrinol Metab; 1991 Feb; 72(2):374-81. PubMed ID: 1991807
[TBL] [Abstract][Full Text] [Related]
7. Circulating levels of growth hormone, insulin-like growth factor-I and growth hormone binding protein in normal women of advanced reproductive age.
Klein NA; Battaglia DE; Miller PB; Soules MR
Clin Endocrinol (Oxf); 1996 Mar; 44(3):285-92. PubMed ID: 8729523
[TBL] [Abstract][Full Text] [Related]
8. Comparison of pharmacodynamic properties of various estrogen formulations.
Mashchak CA; Lobo RA; Dozono-Takano R; Eggena P; Nakamura RM; Brenner PF; Mishell DR
Am J Obstet Gynecol; 1982 Nov; 144(5):511-8. PubMed ID: 6291391
[TBL] [Abstract][Full Text] [Related]
9. Suppression of sex steroids by a gonadotrophin-releasing hormone agonist increases serum growth hormone-binding protein activity in girls with central idiopathic precocious puberty.
Kobayashi Y; Murata A; Yasuda T; Minagawa M; Wataki K; Ohnishi H; Niimi H
Clin Endocrinol (Oxf); 1994 Mar; 40(3):351-5. PubMed ID: 8187298
[TBL] [Abstract][Full Text] [Related]
10. Estrogens exert route- and dose-dependent effects on insulin-like growth factor (IGF)-binding protein-3 and the acid-labile subunit of the IGF ternary complex.
Kam GY; Leung KC; Baxter RC; Ho KK
J Clin Endocrinol Metab; 2000 May; 85(5):1918-22. PubMed ID: 10843175
[TBL] [Abstract][Full Text] [Related]
11. Inhibitory action on GHRH-induced GH secretion of chronic tamoxifen treatment in breast cancer.
De Marinis L; Mancini A; Izzi D; Bianchi A; Giampietro A; Fusco A; Liberale I; Rossi S; Valle D
Clin Endocrinol (Oxf); 2000 Jun; 52(6):681-5. PubMed ID: 10848871
[TBL] [Abstract][Full Text] [Related]
12. Effect of growth hormone administration frequency on 24-hour growth hormone profiles and levels of other growth related parameters in girls with Turner's syndrome. Dutch Working Group on Growth Hormone.
van Teunenbroek A; de Muinck Keizer-Schrama SM; Stijnen T; Mouton JW; Blum WF; Mercado M; Baumann G; Drop SL
Clin Endocrinol (Oxf); 1993 Jul; 39(1):77-84. PubMed ID: 7688672
[TBL] [Abstract][Full Text] [Related]
13. Differential effects of oral conjugated estrogens and transdermal estradiol on insulin-like growth factor 1, growth hormone and sex hormone binding globulin serum levels.
Campagnoli C; Biglia N; Altare F; Lanza MG; Lesca L; Cantamessa C; Peris C; Fiorucci GC; Sismondi P
Gynecol Endocrinol; 1993 Dec; 7(4):251-8. PubMed ID: 8147234
[TBL] [Abstract][Full Text] [Related]
14. Reduced androgen levels in adult turner syndrome: influence of female sex steroids and growth hormone status.
Gravholt CH; Svenstrup B; Bennett P; Sandahl Christiansen J
Clin Endocrinol (Oxf); 1999 Jun; 50(6):791-800. PubMed ID: 10468952
[TBL] [Abstract][Full Text] [Related]
15. Impact of short-term estrogen administration on growth hormone secretion and action: distinct route-dependent effects on connective and bone tissue metabolism.
Ho KK; Weissberger AJ
J Bone Miner Res; 1992 Jul; 7(7):821-7. PubMed ID: 1642149
[TBL] [Abstract][Full Text] [Related]
16. Influence of low dose oestrogen on circulating prolactin. LH and FSH levels in post-menopausal women.
Robyn C; Vekemans M
Acta Endocrinol (Copenh); 1976 Sep; 83(1):9-14. PubMed ID: 989226
[TBL] [Abstract][Full Text] [Related]
17. Relation between plasma hormone profiles, symptoms, and response to oestrogen treatment in women approaching the menopause.
Chakravarti S; Collins WP; Thom MH; Studd JW
Br Med J; 1979 Apr; 1(6169):983-5. PubMed ID: 219937
[TBL] [Abstract][Full Text] [Related]
18. Overnight secretion pattern of growth hormone, sex hormone binding globulin, insulin-like growth factor-1 and its binding protein in obese and non-obese women with polycystic ovarian disease.
Insler V; Barash A; Shoham Z; Koistinen R; Seppala M; Hen M; Lunenfeld B; Zadik Z
Isr J Med Sci; 1994 Jan; 30(1):42-7. PubMed ID: 7511134
[TBL] [Abstract][Full Text] [Related]
19. Comparison of hepatic impact of oral and vaginal administration of ethinyl estradiol.
Goebelsmann U; Mashchak CA; Mishell DR
Am J Obstet Gynecol; 1985 Apr; 151(7):868-77. PubMed ID: 3920910
[TBL] [Abstract][Full Text] [Related]
20. Oestrogen effects on calcitriol levels in post-menopausal women: a comparison of oral versus transdermal administration.
Dick IM; Prince RL; Kelly JJ; Ho KK
Clin Endocrinol (Oxf); 1995 Aug; 43(2):219-24. PubMed ID: 7554318
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
